Healthcare leaders are constantly challenged by changing regulations and new technologies, so the organizations they run must be agile enough to adapt to these changing circumstances.
A new lawsuit this week alleges that Boston Scientific ran a conspiracy to use counterfeit materials from China to make its transvaginal surgical mesh devices, which have been the target of criticism and thousands of lawsuits from injured patients in recent years.
Lawmakers say health insurance claims should carry codes to improve tracking and monitoring of device safety and efficacy after a damning report found the number of deadly infections associated with the use of contaminated medical scopes far exceeds previous estimates.
Marin General Hospital in Greenbrae, Calif., has entered into a 15-year, $90 million agreement with medical equipment manufacturer Royal Philips that will provide the hospital with medical technologies and consulting services. It's part of Royal Philips' strategic effort to partner with health...
Independence Blue Cross will begin including whole genome sequencing for some cancers as a covered benefit starting this spring, the health insurer said Monday.
The current generation of wearable medical devices tend to be bulky, boxy and more like wearing a small machine than something that works with your body. And the data typically aren't transmitted directly to the healthcare provider. But technology company MC10 aims to change that.
One of the nation's leading endocrinologists warns that a so-called "artificial pancreas" touted as a game-changer for the treatment of diabetes could also bring headaches to the industry as it learns how to get reimbursed for advice given in between visits.
Healthcare price transparency is slowly gaining ground as employers become more cost conscious, and consumers have to pay more out of pocket under high-deductible health plans.
Between 2006 and 2014 the number of trials paid for by industry rose 43%, while those funded by the NIH dropped 24%, according to a new study in JAMA. Researchers say industry-funded studies concentrate on commercial purposes and don't measure comparative effectiveness.
Dr. Thomas Graham is leaving the Cleveland Clinic, forcing the institution to replace another leader within its much-praised innovations unit.
Quest Diagnostics will do away with stand-alone antibody screening for hepatitis C, instead opting to automatically test anyone whose results show they've been exposed to the virus, the company announced on Thursday.
Safeway is partnering up with Sonora Quest Laboratories after dumping Theranos. Sonora, a joint venture of Banner Health and Quest Diagnostics, will open patient-service centers in Arizona Safeway stores, starting with a north Scottsdale location already open.